Exactly! He could not outright say he recommended an under 1B MC company with no revenues; however, it seems he's bullish on Anavex and secretly believes Anavex has a decent chance of good Alzheimer's results. Otherwise, he wouldn't have highlighted this company on his show, at this time, and say he "liked it" and gives his "blessing" for a spec play, on more than one episode.
He's dropping a hint (or two) to whoever gets it, and like you said, he needs to hedge because, from a cursory look and based on others past Alzheimer's results, it would seem like a long shot high risk gamble, especially with a pre-revenue company. Not everyone has had the blessing to follow Anavex for years (7 here) and see the results, biomarker discoveries, third party confirmation, peer reviews; Mayo's, falconer's and others detailed analysis, etc. play out and always confirming our MOA.
Also, after the META debacle, this would be a big win for him. He's opened the door to highlight and recommend Anavex more after a successful TLR and also gets to take a bit of credit for the wink. After a successful TLR, I'm sure he and many others will spend more time researching our company and then will be able to highlight our platform, MOA, and many other indications more accurately.
There's so many other stocks out there so no reason to waste a Mad Money segment on Anavex if he didn't think there was something interesting going on here. Easy enough to just ignore us like everyone else and keep pumping Lilly, or just bash without stating he liked it and without giving his blessing to buy it.
It's going to be very exciting times for us here soon and the excitement will last for many years with our platform, limitless indications, and 371 on deck!
